PharmEasy parent cuts FY26 loss 67%
By Abha Lohia ·
PharmEasy: funding and every story →
- PharmEasy is an online pharmacy and diagnostics platform run by its parent company, API Holdings
- API Holdings reported a loss of ₹520 crore for the financial year 2025-26, which is 67% lower than a year earlier
- The smaller loss follows its debt clean-up earlier in October and talk of a possible return to the IPO route
What happened
- API Holdings posted a ₹520 crore loss for FY26.
- The loss fell 67% from the year before.
Why it matters
- Smaller losses help the case for a future IPO.
The business
- PharmEasy sells medicines and runs diagnostics online.
The founders
In numbers
₹520 CrFY26 loss · 2026
Terms in this story
- IPO: An IPO, or initial public offering, is the first time a company sells its shares to the general public and gets listed on a stock exchange. In India the process is supervised by SEBI and ends with the shares trading on the NSE and BSE.
Everything on PharmEasy → · All startup news on 12 October 2026 →
Is this PharmEasy? Get your “Featured on StopDown” badge →